Brii Biosciences Limited (BRIBF)
USD 0.13
(0.0%)
USD 0.13
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 55.89 Million CNY | -84.75% |
| 2022 | 51.62 Million CNY | 254.52% |
| 2021 | 14.56 Million CNY | 15.62% |
| 2020 | 12.59 Million CNY | 334.24% |
| 2019 | 2.9 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 686.02 Thousand USD | 0.0% |
| 2024 Q1 | 1.53 Million USD | 36.55% |
| 2023 Q4 | -990.2 Thousand USD | -189.11% |
| 2023 FY | 7.87 Million CNY | -84.75% |
| 2023 Q3 | 1.11 Million USD | 1148.23% |
| 2023 Q2 | 89.01 Thousand USD | -96.95% |
| 2023 Q1 | 2.91 Million USD | -60.63% |
| 2022 Q2 | -1.27 Million USD | 0.0% |
| 2022 FY | 51.62 Million CNY | 254.52% |
| 2022 Q4 | 7.41 Million USD | 0.0% |
| 2021 FY | 14.56 Million CNY | 15.62% |
| 2021 Q4 | -1.43 Million USD | 0.0% |
| 2021 Q2 | -1.23 Million USD | 0.0% |
| 2020 Q2 | -914.71 Thousand USD | 0.0% |
| 2020 FY | 12.59 Million CNY | 334.24% |
| 2020 Q4 | -1.14 Million USD | 0.0% |
| 2019 FY | 2.9 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -272.632% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -1801673.05% |
| SQZ Biotechnologies Company | 9.79 Million USD | -470.666% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -377.456% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 53.075% |
| Mesoblast Limited | -35.16 Million USD | 258.926% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 163763.25% |
| Genus plc | 178.7 Million USD | 68.724% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -13526.467% |
| Marizyme, Inc. | 457.7 Thousand USD | -12111.22% |
| ContraFect Corporation | -154 Thousand USD | 36392.857% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 508200.0% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 111882.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -72711.714% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -84933.776% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 14523.447% |
| MultiCell Technologies, Inc. | 49.32 USD | -113323095.458% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -38.808% |
| EV Biologics, Inc. | 48.9 Thousand USD | -114196.524% |
| Q BioMed Inc. | -8988.00 USD | 621940.231% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -97.809% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 362463.849% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 74.607% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -79744.286% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 45082.334% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -89719.368% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 1128755.089% |
| Arch Therapeutics, Inc. | -2439.00 USD | 2291653.916% |
| IMV Inc. | -962.29 Thousand USD | 5908.076% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -39680.071% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 57415.285% |
| GB Sciences, Inc. | -624.00 USD | 8956991.026% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 65068.382% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.261% |
| Halberd Corporation | -208.00 USD | 26870773.077% |
| Enzolytics Inc. | 30.7 Thousand USD | -181907.946% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -4018.284% |
| SYBLEU INC | 11.69 Thousand USD | -477764.227% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -11485.236% |
| argenx SE | 1.1 Billion USD | 94.958% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 316.649% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -8952.875% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 86.353% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 631208.853% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -26.0% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 4995.968% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -5557.093% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -481.532% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 66756.728% |
| BioStem Technologies, Inc. | 15.42 Million USD | -262.344% |
| ONE Bio Corp. | 20.12 Million USD | -177.713% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 472351.796% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 115914.667% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -31555.528% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -31555.528% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 10962.957% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 8969.644% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 192827.586% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -12319.036% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 17592.887% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -1112.912% |
| Bioxytran, Inc. | -8285.00 USD | 674704.707% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 15084.182% |
| Neutra Corp. | 14.33 Thousand USD | -389791.873% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 68259.756% |
| PureTech Health plc | -1.6 Million USD | 3586.65% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 5682.2% |
| IXICO plc | 3.27 Million USD | -1609.205% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 8153.458% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 3220.659% |
| CSL Limited | 7.7 Billion USD | 99.275% |
| Cellectis S.A. | 18 Thousand USD | -310405.556% |